Search results for "Pyrazole"

The alpha and ßeta in phase II trials hepatocellular carcinoma ‐ A tale of more than radiological response?

2019

Pyrazole[3,4-d]pyrimidine derivatives loaded into halloysite as potential CDK inhibitors

2021

Uncontrolled cell proliferation is a hallmark of cancer as a result of rapid and deregulated progression through the cell cycle. The inhibition of cyclin-dependent kinases (CDKs) activities is a promising therapeutic strategy to block cell cycle of tumor cells. In this work we reported a new example of nanocomposites based on halloysite nanotubes (HNTs)/pyrazolo[3,4-d]pyrimidine derivatives (Si306 and Si113) as anticancer agents and CDK inhibitors. HNTs/Si306 and HNTs/Si113 nanocomposites were synthesized and characterized. The release kinetics were also investigated. Antitumoral activity was evaluated on three cancer cell lines (HeLa, MDA-MB-231 and HCT116) and the effects on cell cycle ar…

In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic pha…

2012

The in vitro and in vivo anti- Trypanosoma cruzi activity of the pyrazole-containing macrobicyclic polyamine 1 and N-methyl- and N-benzyl-substituted monocyclic polyamines 2 and 3 was studied. Activity against both the acute and chronic phases of Chagas disease was considered. The compounds were more active against the parasite and less toxic against Vero cells than the reference drug benznidazole, but 1 and 2 were especially effective, where cryptand 1 was the most active, particularly in the chronic phase. The activity results found for these compounds were complemented and discussed by considering their inhibitory effect on the iron superoxide dismutase enzyme of the parasite, the nature…

Dopamine interaction with a polyamine cryptand of 1H-pyrazole in the absence and in the presence of Cu(ii) ions. Crystal structure of [Cu2(H−1L](ClO4…

2000

The crystal structure of the binuclear Cu2+ complex [Cu2(H−1L)](ClO4)3 ·2H2O of the cryptand L = 1,4,7,8,11,14,17,20,21,24,29,32,33,36-tetradecaazapentacyclo[12.12.12.1 6,9.119,22,1,31,34]hentetraconta-6,9(41), 19(40), 21,31,34(39)-hexaene is presented; evidence for the formation in solution of binary L–dopamine and ternary Cu2+–L–dopamine complexes is presented.

6-Amino-1-benzyl-4-(4-chloro-phen-yl)-3-(4-pyrid-yl)-1,4-dihydro-pyrano[2,3-c]pyrazole-5-carbonitrile.

2008

The crystal structure of the title compound, C25H18ClN5O, was determined in the course of our studies on the synthesis of 1,4-dihydropyrano[2,3-c]pyrazole as an inhibitor of the p38 mitogen-activated protein kinase (MAPK). The compound was prepared via a base-catalysed synthesis from 1-benzyl-3-(4-pyridyl)-1H-pyrazol-5(4H)-one with p-chloroaldehyde and malononitrile. The crystal data obtained were used to generate a three-dimensional pharmacophore model for in silico database screening. The phenyl ring is disordered over two positions, with site occupancy factors of 0.55 and 0.45. The dihedral angles between the 1,4-dihydropyrano[2,3-c]pyrazole unit and the chlorophenyl and pyridine rings a…

Improving the photocatalytic H2 evolution activity of Keggin polyoxometalates anchoring copper-azole complexes

2021

Eliminating the use of precious metals as cocatalysts and using visible light are two important aspects in the field of photocatalytic H2 evolution with polyoxometalates (POMs) as photosensitizers. Here we present two new POM-based materials: [CuII5(2-ptz)6(H2O)4(GeW12O40)]·4H2O (1) and [CuI2(ppz)4][H2GeW12O40]·8H2O (2) (2-ptz = 5-(2-pyridyl) tetrazole, ppz = 3-(pyrid-4-yl) pyrazole) synthesized with the Keggin type [GeW12O40]4− (GeW12) polyanion and copper-azole complexes. The optimum photocatalytic H2 evolution rate of compound 1 without a noble metal cocatalyst is 3813 μmol g−1 h−1, which is 7.6 times higher than that of compound 2 and more than 27 times higher than that of bare GeW12 po…

Synthesis and spectroscopic investigations (IR, NMR and Mössbauer) of tin(IV) and organotin(IV) derivatives of bis(pyrazol-1-yl) alkanes: X-ray cryst…

1995

A series of 1:1 adducts of the type [(L)R(n)SnX(4-n)] . zH(2)O (L = bis(4-methylpyrazol-1-yl)methane (L(4)), bis(3,4,5-trimethylpyrazol-1-yl)methane (L(T)), 1,2-bis(pyrazol-1-yl)ethane (L(A)) or 1,2-bis(3,5-dimethylpyrazol-1-yl)ethane (L(B)); R = Me, Et, Bu or Ph; X = I, Br or Cl; n = 0, 1 or 2; z = 1, 1.5 or 2), and the likely polynuclear [(L(A))(5)(SnCl4)(4)] . (H2O)(5) and [(L(B))(2)(SnCl4)(3)] . 1/2[Et(2)O] have been characterized in the solid state and in solution by analyses, spectral (IR, Mossbauer, and H-1, C-13 and Sn-119 NMR) data and conductivity measurements. When L(T) reacts with SnCl4, cleavage of a carbon (sp(3))-nitrogen bond was observed and the adduct [(3,4,5-trimethylpyra…

Bis[3-methyl-5-(pyridin-2-yl)-1H-pyrazol-4-yl] selenide methanol hemisolvate

2014

The asymmetric unit of the title compound, C18H16N6Se·0.5CH3OH, contains two independent molecules of bis[3-methyl-5-(pyridin-2-yl)-1H-pyrazol-4-yl] selenide with similar C—Se—C bond angles [99.30 (14) and 98.26 (13)°], and a methanol molecule of solvation. In one molecule, the dihedral angles between pyrazole and neighbouring pyridine rings are 18.3 (2) and 15.8 (2)°, and the corresponding angles in the other molecule are 13.5 (2) and 8.3 (2)°. In the crystal, the selenide and solvent molecules are linked by classical O—H...N and N—H...N hydrogen bonds, as well as by weak C—H...O and C—H...π interactions, forming a three-dimensional supramolecular architecture.

4-(4-Fluorophenyl)-1-(4-nitrophenyl)-3-(pyridin-4-yl)-1H-pyrazol-5-amine

2012

In the crystal structure of the title compound, C20H14FN5O2, the pyrazole ring forms dihedral angles of 59.3 (2), 25.6 (2) and 46.0 (2)° with the directly attached 4-fluorophenyl, pyridine and nitrophenyl rings, respectively. The crystal packing is characterized by intermolecular N—H...N and N—H...O hydrogen bonds.

Curcumin-derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer's disease?

2007

Curcumin binds to the amyloid beta peptide (Abeta) and inhibits or modulates amyloid precursor protein (APP) metabolism. Therefore, curcumin-derived isoxazoles and pyrazoles were synthesized to minimize the metal chelation properties of curcumin. The decreased rotational freedom and absence of stereoisomers was predicted to enhance affinity toward Abeta(42) aggregates. Accordingly, replacement of the 1,3-dicarbonyl moiety with isosteric heterocycles turned curcumin analogue isoxazoles and pyrazoles into potent ligands of fibrillar Abeta(42) aggregates. Additionally, several compounds are potent inhibitors of tau protein aggregation and depolymerized tau protein aggregates at low micromolar …